- Home
- PRHI vs PMI Comparison
PRHI vs PMI Comparison
Compare PRHI & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | PRHI | PMI |
|---|---|---|
| Founded | 2009 | 1981 |
| Country | United States | United States |
| Employees | 9 | 75 |
| Industry | Property-Casualty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2M | 14.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRHI | PMI |
|---|---|---|
| Price | $5.34 | $0.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.7K | ★ 6.7M |
| Earning Date | 05-13-2026 | 06-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.48 | $0.11 |
| 52 Week High | $6.40 | $13.68 |
Technical Indicators
Market Signals| Indicator | PRHI | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 59.58 | 35.26 |
| Support Level | $0.60 | $0.11 |
| Resistance Level | $5.34 | $0.20 |
| Average True Range (ATR) | 0.32 | 0.02 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 40.71 | 2.02 |
Price Performance
Historical ComparisonAbout PRHI Presurance Holdings Inc.
Presurance Holdings Inc Formerly Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.